Navigation Links
Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results
Date:8/5/2008

t expenses, sales, marketing and distribution expenses, and general and administrative expenses, based on the nature of the work the Company's employees were assigned to perform, totaled RMB6.4 million (US$0.9 million) for the second quarter of 2008. The share-based compensation expenses for the second quarter of 2007 were RMB7.7 million. For the first six months of 2008, share-based compensation expenses totaled RMB13.4 million (US$2.0 million), a decrease of 7.5% from RMB14.5 million for the first six months of 2007.

Operating income was RMB98.1 million (US$14.3 million) for the second quarter of 2008, representing an increase of 73.9% as compared to RMB56.4 million for the corresponding period of 2007. For the first six months of 2008, operating income was RMB197.3 million (US$28.8 million), an increase of 51.3% as compared to RMB130.5 million in the corresponding period in 2007.

Income tax expense for the second quarter of 2008 totaled RMB18.1 million (US$2.6 million) compared to an income tax credit of RMB4.0 million for the corresponding period of 2007. For the first six months of 2008, income tax expense was RMB34.9 million (US$5.1 million) compared to an income tax credit of RMB2.5 million for the first six months of 2007. In addition to the overall increase in taxable income, the increased income tax expense in 2008 was primarily due to the expiration of tax holidays enjoyed by two PRC subsidiaries.

Net income was RMB95.2 million (US$13.9 million) for the second quarter of 2008, compared to RMB83.1 million in the corresponding period a year ago and representing growth of 14.5%. The Company's net margin (net income as a percentage of total revenue) was 21.8% for the second quarter of 2008 compared to 24.9% for the second quarter of 2007. For the first six months of 2008, net income was RMB207.3 million (US$30.2 million), an increase of 38.1% as compared to RMB150.1 million for the first six months of 2007. Net margin for the first six mo
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
2. Simcere Pharmaceutical Group Reports Third Quarter 2007 Results
3. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
4. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
5. Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.s Fourth Investor Tour of China
6. Simcere Pharmaceutical Group to Announce First Quarter 2008 Earnings on Tuesday, May 6, 2008
7. Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd.
8. Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
9. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... February 26, 2015 Wound Care ... management, recently expanded its executive team by adding three ... experience. At the same time two WCA team members ... Care Advantage (WCA) was founded in 2002 and is ... operating today. The WCA team believes that providing outstanding ...
(Date:2/26/2015)... In a nested-case control study of individuals ... a relatively low incidence of liver cancer, statin use is ... to a new study published February 26 in the ... studies have reported this association but most used data from ... rate, such as Asia. Katherine A. McGlynn, Ph.D., from the ...
(Date:2/26/2015)... February 26, 2015 Software and ... FDA’s Position and Best Practices for Compliance, **Presented ... Bethesda, MD, http://www.fdanews.com/SoftwareAndCybersecurity , This workshop ... — has been specifically designed to provide attendees ... effectively assure medical device software safety. , In ...
(Date:2/26/2015)... 2015 Deep Market Research Report on ... study on the current state of the global ... the Chinese situation. , Major companies included in ... Hu-Friedy, Medisporex, Towne Brothers, Teleflex Medical, Landanger, YDM, ... Equipment, Shuanglu, Changshu Henry Medical Instrument, and Kangqiao ...
(Date:2/26/2015)... York, New York (PRWEB) February 26, 2015 ... lawsuits ( http://www.xareltolawsuit2015.com/ ) continues to move forward ... Louisiana, Bernstein Liebhard LLP reports. According to court ... on February 13, 2014. (In Re: Xarelto Products ... that the Court has established standards and procedures ...
Breaking Medicine News(10 mins):Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 4Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 2Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 3Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 4Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 2Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 3Health News:Federal Xarelto Lawsuits Progress, As Bernstein Liebhard LLP Comments on Issuance of Most Recent Pretrial Order 2Health News:Federal Xarelto Lawsuits Progress, As Bernstein Liebhard LLP Comments on Issuance of Most Recent Pretrial Order 3
... Pa., Oct. 2 MEDRAD,s Heilman Center,electro-mechanical ... has been,selected as a 2007 IndustryWeek magazine ... to plants that are on the leading ... satisfaction, and create,stimulating and rewarding work environments. ...
... Europeans when it comes to chronic disease care, study ... is a big factor driving soaring rates of chronic ... chronically ill than their European counterparts, a new study ... researchers, chronic illnesses such as diabetes and heart disease ...
... can be the worst news a cancer patient ever ... Missouri-Columbia is working steadfastly to learn why some tumors ... cisplatin, in hopes of identifying the particular genes that ... possible. , In a paper published in the latest ...
... adult suffers a cardiorespiratory arrest the rapid application of ... death in many cases. Nevertheless, defibrillation also has its ... from the moment of the attack, the possibilities of ... to avoid avoidable deaths, more and more easy-to-handle, automatic ...
... a division of,Filtrona plc, developer of fiber-based capillary ... the completion,of the recent expansion of its plant ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061127/DCM011LOGO ) The expansion ... size of,production floor space and an expanded analytical ...
... GmbH, Campbell,CA, is pleased to announce that due to ... to larger premises in Northern,California where its US operations ... be located at joimax, Inc. 275 E. ... move reflects the strong growing activities on the US ...
Cached Medicine News:Health News:MEDRAD Plant Named IndustryWeek Magazine Award Finalist 2Health News:MEDRAD Plant Named IndustryWeek Magazine Award Finalist 3Health News:Obesity Driving Rising U.S. Health Costs 2Health News:Obesity Driving Rising U.S. Health Costs 3Health News:MU researchers studying model to learn why certain cancers become resistant to drugs 2Health News:Algorithms to reanimate the heart 2Health News:Algorithms to reanimate the heart 3Health News:Filtrona Fibertec Ningbo, China Plant Celebrates Expansion 2
(Date:2/26/2015)... February 26, 2015 The ... Bottle washer, Filler, Capper, Blow molder, Shrink wrapper), ... (Still, Flavored, Sparkling) & Region - Trends & ... segments the bottled water processing market with analyses ... terms of value. It also identifies the driving ...
(Date:2/26/2015)... 26, 2015 People with psoriasis and ... to participate in research that aims to improve ... U.S. psoriasis registry begins recruiting patients in 2015. ... the National Psoriasis Foundation and Corrona, LLC, will ... a new biologic medication by Novartis Pharmaceuticals for ...
(Date:2/26/2015)...  MEI Pharma, Inc. (Nasdaq: MEIP ), an ... for cancer, announced today that Daniel P. Gold , ... Cowen and Company 35 th Annual Health Care Conference ... from the Boston Marriott Copley Place. A live webcast of ... replay will be available approximately one hour after the presentation. ...
Breaking Medicine Technology:Bottled Water Processing Market Worth $2,106.5 Million by 2019 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 3Bottled Water Processing Market Worth $2,106.5 Million by 2019 4First independent U.S. psoriasis registry will track drug safety and effectiveness 2First independent U.S. psoriasis registry will track drug safety and effectiveness 3MEI Pharma to Present at Cowen and Company Health Care Conference 2MEI Pharma to Present at Cowen and Company Health Care Conference 3
... DIEGO, Sept. 7, 2011 Anadys Pharmaceuticals, Inc. (Nasdaq: ... the Company,s direct-acting antiviral (DAA) currently in Phase IIb ... of Windhover,s Top 10 Most Interesting Infectious Disease Projects ... setrobuvir identified as a Top 10 infectious disease project," ...
... 2011 Bankers Life and Casualty Company and Humana ... strategic alliance under which Bankers, agent force will offer ... across the United States.  Beginning in October, Bankers agents ... a suite of Humana Medicare products including Medicare Advantage ...
Cached Medicine Technology:Anadys' Setrobuvir Named One of Windhover's Top 10 Most Interesting Infectious Disease Projects to Watch 2Anadys' Setrobuvir Named One of Windhover's Top 10 Most Interesting Infectious Disease Projects to Watch 3Anadys' Setrobuvir Named One of Windhover's Top 10 Most Interesting Infectious Disease Projects to Watch 4Bankers Life and Casualty Company Partners with Humana to Offer Humana Medicare Prescription Drug Plans 2
Compact tray features all components for urethral catheterization....
... first time, the Integrated Cytometry Solution ... post-analytical solution coupled with complete LIS ... steps a sample undergoes - and ... one - it delivers a progressive ...
Convective Air Warming Blankets...
MAMMOMAT 3000 Nova supports high-volume screening as well as interventional diagnostics. Versatile procedural capabilities include magnification, stereotactic biopsy, needle localization, and specime...
Medicine Products: